Few Usable Embryos: What to Prepare and Ask Before IVF in Thailand

A low number of usable embryos is not a single problem with a single fix. It is the end result of a chain: how many eggs were collected, how many were mature, how they were fertilised, how many reached the blastocyst stage, and — if testing was used — how many survived that step. Each link in that chain can be reviewed, and each raises different questions for a licensed clinician.

This guide is for the preparation stage: the weeks before you commit to a cycle in Thailand. It does not tell you what treatment to have. It helps you arrive at a consultation with the right records, a realistic set of questions, and a plan for how many cycles you might need to budget for.

Start with the records, not the protocol

Before any discussion about changing stimulation drugs or adding a laboratory technique, a clinician needs to see what actually happened last time. Ask your previous clinic for a written cycle summary and the laboratory report, not just a discharge letter. If you are gathering documents from more than one clinic, keep them in date order.

A useful record set usually includes:

• Oocyte yield and maturity: how many eggs were retrieved, and how many were mature at the time of insemination.
• Fertilisation method and result: standard insemination or ICSI, and how many eggs fertilised normally.
• Cleavage and blastocyst conversion: how many embryos were still developing on each recorded day, and how many reached blastocyst.
• Embryo grading and freezing: which embryos were transferred, frozen or discarded, and the stated reason.
• Stimulation record: starting dose, adjustments, number of monitoring days, trigger type and timing.
• Any genetic testing: how many embryos were biopsied, how many returned a result, and how the report described each one.
• Relevant background: age at the cycle, prior surgery, known diagnoses, and any male-factor findings.

These records do not diagnose anything on their own. What they do is let a clinician see where attrition happened, which is the starting point for any conversation about what might be adjusted.

Where embryos are lost, and what each point raises

It helps to think in stages rather than in one lump. The table below is a discussion map, not a treatment plan.

Stage	What the record shows	Question for the clinician
Egg collection	Total eggs retrieved against the stimulation record	Was the response what you expected from my protocol, and what would you change next time?
Maturity	Mature eggs as a share of those retrieved	Does the maturity pattern suggest anything about trigger timing or protocol choice?
Fertilisation	Fertilised eggs by method used	Was ICSI used, and what was the reasoning? Would you reason differently now?
Blastocyst development	Embryos reaching blastocyst, with grading	How do you read the development pattern, and does laboratory practice play a part?
Testing (if used)	Embryos biopsied and results reported	Given how few embryos we had, was testing the right trade-off?

Each row is a place where a clinician may see something worth adjusting — or may see nothing that a change would reliably improve. Both answers are useful. A plan built on the assumption that every cycle can be improved is not a plan; it is a hope with a schedule attached.

Clinical discussion points to raise in consultation

These are categories to ask about, not recommendations. Which apply to you depends on your history, and only the treating clinician can judge that.

Stimulation protocol review

Ask how your previous starting dose, drug choice and monitoring frequency compare with what the clinic would propose now, and why. Ask specifically whether a different protocol is expected to change egg numbers, egg quality, or neither. A protocol change that only increases the number of eggs collected without improving the number of usable embryos may not change the outcome you care about.

Trigger timing

The trigger decides when eggs are collected. Ask whether the maturity figures from your last cycle suggest the timing was right, and how the clinic monitors for that.

Sperm selection and ICSI rationale

If male-factor findings are part of your history, ask whether ICSI is planned and on what basis. If a laboratory technique beyond standard ICSI is being suggested, ask what evidence supports it. Regulators have looked at some of these add-ons and found the evidence insufficient to show they improve the chance of having a baby; the HFEA review of IMSI, for example, reports insufficient moderate- or high-quality evidence that it improves outcomes over standard ICSI, including in male-factor infertility. That does not make it forbidden — it makes it something to ask about rather than assume.

Laboratory culture and freezing practice

When embryos are few, laboratory handling matters more, simply because there is less margin. Ask how the laboratory decides which embryos to culture to blastocyst and which to freeze earlier, how vitrification is handled, and who you can speak to if you have questions about the embryology report. You are not expected to audit a laboratory; you are entitled to ask how decisions about your embryos are made and recorded.

Whether PGT is worth the attrition

This is the hardest trade-off in a low-yield situation. PGT-A assesses chromosome number in cells sampled from an embryo, and the HFEA notes that testing has limitations and can produce incorrect findings, and that a result does not guarantee a successful pregnancy or a healthy child. Biopsy itself carries a risk: the same regulator states that biopsy can cause damage and prevent further development. With many embryos, that risk is spread across a pool. With two or three, it is concentrated.

Ask your clinician directly: given my embryo numbers, what do I gain and what might I lose by testing? Ask what happens to embryos with an uncertain or mosaic result, and whether a reported finding from a sample can be treated as a whole-embryo diagnosis. The ASRM committee opinion on mosaic results is clear that a sampled result does not establish the cell composition of the whole embryo, and that technical factors can contribute to such findings. If your reason for testing is a known inherited condition rather than chromosome number, that is a different test with a different design conversation — see our guide to PGT-M testing in Thailand for couples at risk of genetic disorders.

Planning how many cycles, and in what order

With few usable embryos, the practical question shifts from “will this cycle work” to “how many cycles might this take, and how do I want to sequence them”. Ask about:

• Cumulative planning: how the clinic thinks about chances across more than one cycle rather than a single transfer.
• Embryo banking: whether collecting and freezing across cycles before any transfer is an option in your situation, and what that means for timing and cost.
• Fresh versus frozen transfer: whether a fresh transfer is planned or whether all embryos will be frozen, and why. Our article on fresh and frozen transfer pathways explains how these are planned as separate stages.
• Stopping rules: what the clinic would want to see after a cycle to decide whether to continue, change approach, or discuss other routes. Agreeing this in advance makes later decisions less reactive.

Ask for the answer in ranges and contingencies, not a single number. Any clinician who gives you a firm figure for a low-yield situation is guessing more confidently than the evidence allows.

Pre-treatment preparation you can actually do

Much of the preparation for a low-yield cycle is administrative and informational rather than physical. What you can do before travel:

1. Assemble the record set described above, in English where available, and note anything missing.
2. Write your question list in priority order, with the two or three questions you most need answered at the top.
3. Request a remote consultation and confirm the format, who will attend, the fee, and which records to send ahead.
4. Ask what the quotation includes — specifically laboratory fees, freezing and storage, biopsy and testing fees if relevant, and what happens to the price if a cycle is cancelled before collection.
5. Check the timeline against your own commitments. A low-yield plan may involve more than one trip; our guide to how long to stay in Thailand for a PGT cycle is a useful starting point for that conversation.
6. Decide who will hold your records and how results will reach you and your home clinic afterwards.

On the clinical side, ask your treating clinician what, if anything, they want you to do or avoid in the weeks before a cycle. Do not start, stop or change any medication on the basis of general reading, including this article; that instruction belongs to your prescriber.

What coordination can and cannot do

If you use a coordination service, the useful split is straightforward. A coordinator can help organise your records into a dated set, draft and translate your question list, request appointments and remote consultations, confirm what a quotation includes and what remains unconfirmed, and help arrange records handover after you return home. A coordinator does not interpret your results, recommend a protocol, or tell you whether to test your embryos — those are conversations with your treating clinician and, where relevant, a genetic counsellor.

If you would like help preparing a case summary and question list before approaching a hospital in Thailand, you can request a case review. If you are still at the stage of comparing where to be treated, our article on researching IVF hospital options across Thailand sets out comparison criteria; it is a starting point for your own shortlist, not a statement about which provider is better.

The preparation checklist

• Previous cycle summary and laboratory report requested, in date order
• Oocyte, maturity, fertilisation, blastocyst and testing figures written down
• Question list drafted, with the PGT trade-off question included if testing is on the table
• Remote consultation requested; format, attendees and fee confirmed
• Quotation inclusions checked, including laboratory, freezing, storage and testing lines
• Number of cycles you could realistically consider discussed, with contingencies
• Records recipient and handover method agreed for after you return home

Few usable embryos is a reason to prepare carefully, not a reason to expect a particular result. The most useful thing you can bring to a consultation in Thailand is a clear record of what happened before and a short list of questions you have not yet had answered.

Frequently asked questions

Does a low number of embryos in a previous cycle mean the next cycle will be the same?

Not necessarily, but it is not predictable from one cycle alone. A clinician reviewing your records may identify a specific point — maturity, fertilisation or blastocyst development — where something could be adjusted, or may find nothing that a change would reliably improve. Ask what your records suggest and what evidence supports any proposed change.

Should I freeze embryos across several cycles before transferring any?

That is a clinical and personal decision. Embryo banking is a planning option some patients discuss when yield is expected to be low, but whether it suits you depends on your history, age, response and what you can practically commit to. Ask your clinician how they would sequence it and what it means for timing and cost.